Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Wilms Tumor 2Osteosarcoma 2Nasopharyngeal Carcinoma 2Multiple Myeloma 2Endometrial Neoplasms 2Thyroid Cancer, Papillary 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Sarcoma, Synovial 1Sarcoma, Ewing 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroblastoma 1Nasopharyngeal Neoplasms 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Lung Neoplasms 1Low Anterior Resection Syndrome 1Liposarcoma, Myxoid 1Immunoglobulin Light-chain Amyloidosis 1Hepatoblastoma 1Epstein-Barr Virus Infections 1Duodenal Neoplasms 1Desmoid Tumors 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Magnetic Resonance Spectroscopy 3X-Rays 2Thyrotropin Alfa 2Specimen Handling 2Iodine-131 2selpercatinib 1gallium Ga 68 dotatate 1cobimetinib 1Vemurafenib 1Phantoms, Imaging 1High-Energy Shock Waves 1Glycoprotein Hormones, alpha Subunit 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Adenocarcinoma, Follicular × Phantoms, Imaging × Clear all
NCT06959641 2026-05-22

XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer

Northwestern University

Phase 2 Recruiting
33 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary, Adenocarcinoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡